Indian company Hetero pulls heart drug from US amid cancer risk probes - Global News | Latest & Current News - Weather, Sports & Health News

Post Top Ad

Responsive Ads Here
At least a dozen companies around the world have pulled specific batches of valsartan from the market since early July, when regulators said valsartan made by the Chinese supplier Zhejiang Huahai Pharmaceuticals had been found to contain a probable human carcinogen

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2P0JFde

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages